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Summary Twenty-one days after s.c. subscapular transplantation of a radiation-induced insulinoma, male
NEDH rats exhibited hyperinsulinaemia and hypoglycaemia. These features were associated with islet
atrophy, degenerative changes in pancreatic A and B cells, and decreases in the pancreatic contents of
insulin, glucagon and somatostatin. The immunoreactive glucagon and somatostatin contents of
extrapancreatic tissues of insulinoma-bearing rats were unchanged. Surgical resection of the tumour
resulted in an immediate fall of plasma insulin, attaining concentrations similar to those of anaesthetised
control rats by 0min. The estimated half-life of insulin was 3.5min. Hypoglycaemia persisted until 60min
after resection, followed by hyperglycaemia of 1-2 days duration. Glucose tolerance was impaired 1 day
after tumour resection despite the coexistence of raised insulin concentrations. Evidence for abnormal
pancreatic B cell function was gained by injection of arginine which failed to evoke a plasma insulin
response in the resected rats. Two days after resection, plasma glucose and insulin concentrations were
similar to those of control rats. Plasma glucose and insulin responses to glucose and arginine were
suggestive of tumour recurrence by 12 days. A single large encapsulated tumour was eventually observed
in each rat, with resection giving a 17-56 day prolongation of life.
Study of insulin-secreting tumours (insulinomas),
the most common type of enteropancreatic
endocrine cancer, has been limited by difficulties of
diagnosis and the sporadic incidence of the disease
in man (Editorial, 1981; Marks & Rose, 1981;
Friesen, 1982). Attention has recently been given to
the induction of serially transplantable insulinomas
in animals, which provide useful models to assist
elucidation of the underlying cellular defects and
the metabolic effects of insulinomas on the regula-
tion of glucose homeostasis. Transplantable islet
cell tumours have been established from single
pancreatic tumours in hamsters and rats which have
arisen either spontaneously, after BK virus in-
noculation, streptozotocin-nicotinamide injection or
X-ray irradiation (Grillo et al., 1967; Hirayama et
al., 1979; Chick et al., 1977, 1980).
The transplantable NEDH rat insulinoma,
developed in the irradiated partner of a pair of
parabiont NEDH rats (Chick et al., 1977), offers
the advantage of high insulin content and rapid
growth rate, resulting consistently in the production
of a localised, highly vascularised encapsulated
tumour at the subscapular implantation site. In
insulinoma-bearing rats of the Surrey subline,
tumour growth is accompanied by the development
of marked hyperinsulinaemia and hypoglycaemia,
leading to neuroglycopaenic coma within one
month (Flatt et al., 1986a). The present study
examines the short and longer-term effects of
tumour resection on glucose homeostasis and the
morphology, hormone content and function of the
endocrine pancreas in recipient NEDH rats. In
addition, the effects of insulinoma transplantation
on glucagon and somatostatin stores have been
examined in selected extrapancreatic tissues.
Materials and methods
Animals
Male inbred albino NEDH (New England Deaconess
Hospital) rats from the colony at the University
of Surrey carrying a serially transplantable
radiation-induced insulinoma (Chick et al., 1977)
were used at 15 weeks of age. The Surrey subline
was established in 1980 from a tumour bearing
rat (B456) and NEDH breeding pairs kindly pro-
vided by Professor W.L. Chick (Boston, USA)
and Professor C.N. Hales (Cambridge, UK). The
rats were housed in an air-conditioned room at
22 +2°C with a lighting schedule of 12 h light
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(0700-1900 h) and 12h dark. A standard pellet diet
(Spratts Laboratory Diet 1, Lillico Ltd., Reigate,
UK) and tap water were supplied ad libitum.
Tumour transplantation and resection
A single s.c. subscapular tumour from a male
donor NEDH rat was used as the source of tumour
fragments for transplantation. After excision of the
tumour, the capsule was removed and the contents
were finely minced. Recipient rats were lightly
anaesthetised with ether, and 0.1 ml of tumour
fragments was implanted subcutaneously into the
subscapular region using a 16 gauge needle.
Resection of the tumour 21 days after trans-
plantation was performed under sodium pento-
barbitone (50mgkg-1 i.p.) anaesthesia. Using aseptic
technique, an incision was made beside the tumour
and adhesions between the tumour capsule and the
surrounding tissues were separated by blunt
dissection. Although the same amount of tumour
fragments was implanted into each rat, the size of
the resulting tumour varied considerably. The
smallest tumour was approximately spherical, 1 cm
in diameter, and the largest tumour was
approximately cylindrical, 4cm long and 1.5cm in
diameter. These corresponded to weights of 1.4g
and 5.1 g respectively. Small tumours were vascular-
ised by numerous small vessels from the
surrounding subcutaneous tissue, and large tumours
were additionally vascularised by several well
defined arteries and veins connected to either the
local cutaneous or underlying muscular vasculature.
Large blood vessels were doubly ligated and
transected, and small vessels were sealed by gentle
pressure and cauterisation. The tumour, with the
capsule intact, was carefully removed, and the
excision site was extensively cleaned with ethanol
and thoroughly checked for removal of all visible
tumour tissue before suturing the wound. Control
rats were anaesthetised and sham operated.
Experimental procedure
Two groups of 12 tumour-bearing rats transplanted
21 days previously and two groups of 12 control
rats were used. In the first experimental series, the
rats were killed by cervical dislocation, and the
pancreas, stomach, duodenum, jejunum, ileum,
colon, kidney and hypothalamus were excised,
cleaned in ice-cold 0.9% NaCl and weighed. A
small piece of the pancreas tail was fixed for 24h in
neutral buffered formalin, dehydrated through
graded ethanols, cleared in toluene and embedded
in paraffin wax for histological and immunocyto-
chemical investigation. The remaining pancreatic
tissue was reweighed and all tissues were extracted
with 5mlg-1 acid-ethanol (750ml ethanol, 250ml
water, 15ml concentrated hydrochloric acid) as
described previously (Flatt et al., 1983). All tissue
extracts were analysed for immunoreactive insulin
and somatostatin. Glucagon-like immunoreactivity
was monitored in extracts of pancreas, duodenum
and ileum.
In the second experimental series, plasma glucose
and insulin concentrations were monitored im-
medately before and after tumour resection at the
times shown in Figure 1. Glucose tolerance tests
were conducted at day 1 and day 12 after tumour
resection, using half of the rats in the group for
each test. Plasma glucose and insulin were deter-
mined immediately before and at 30 and 60min
after an intraperitoneal injection of either glucose
(2gkg-1 in a 40% w/v solution) or arginine hydro-
chloride (2gkg-1 dissolved in 0.9% NaCl).
Blood samples (60p1) for plasma glucose and
insulin measurements were taken at 0900-1400h
from the tail tip in the fed conscious state, except
for rats undergoing surgery. The duration of
sodium pentobarbitone anaesthesia in these rats
was 139+ 14min (mean+s.e., n= 12). The surgical
procedure was commenced 10 minutes after
induction of anaesthesia and normally lasted for
about 20min. The plasma was separated and stored
at -20°C until analysis.
Assays
Plasma glucose was measured by an automated
glucose oxidase procedure (Stevens, 1971). Insulin
was determined by dextran-charcoal radioimmuno-
assay (Flatt & Bailey, 1981) using guinea pig anti-
porcine insulin antiserum (GPB1; PRF/SKS-F),
125I-bovine insulin tracer (Amersham International,
Amersham, UK) and rat insulin standard (Novo
Industria, Copenhagen, Denmark). Glucagon-like
immunoreactivity and somatostatin were also
measured by modified dextran-charcoal radio-
immunoassays (Penman et al., 1979; Flatt &
Swanston-Flatt, 1981) using fully cross-reacting N-
terminal guinea pig antiporcine glucagon antiserum
(GPC1/2: Flatt & Swanston-Flatt, 1981) and rabbit
anticyclic somastostatin antiserum (RG; Penman
et al., 1979) respectively. 125I-porcine glucagon
(J0rgensen & Larsen, 1972) and 1251-tyrosylated
cyclic somatostatin (Penman et al., 1979) were used
as tracers, and porcine glucagon (lot 69/194; WHO
International Laboratory for Biological Standards,
London, UK) and synthetic cyclic somatostatin
(Bachem Inc., California, USA) were used as
standards. Details ofthe sensitivities and specificities
of these assays have been described previously
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Histology and immunocytochemistry
Rehydrated paraffin sections (5gm) were stained
with haematoxylin and eosin, or immunostained by
the indirect immunoperoxidase technique using
guinea pig anti-porcine insulin antiserum (GPB3;
PRF/SKS-F), guinea pig anti-porcine glucagon
antiserum (GPC4; Flatt & Swanston-Flatt, 1981)
and affinity purified donkey anti-guinea pig
immunoglobulin G conjugated to horseradish
peroxidase (Guildhay Antisera, University of
Surrey, Guildford, UK). Somatostatin and PP were
immunostained by the unlabelled peroxidase anti-
peroxidase (PAP) technique (Sternberger, 1979)
using the following antisera: rabbit anti-cyclic
somatostatin (GR21A; Guildhay Antisera), rabbit
anti-bovine pancreatic polypeptide (GR39PD;
Guildhay Antisera), donkey anti-rabbit immuno-
globulin G (Guildhay Antisera) and rabbit PAP
complex (Dakopatts, Glostrup, Denmark). Per-
oxidase activity was visualised using 3,3'-diamino-
benzidine (British Drug Houses, Poole, UK) and
sections were counterstained with Harris haema-
toxylin (British Drug Houses). Control sections
were treated with normal serum instead of the
hormone antisera.
Statistical analysis
Values are presented as mean+s.e., and groups of
data were compared using Student's paired and
unpaired t-tests. Differences were considered to be
significant for P<0.05.
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Results
Implantation of tumour fragments resulted in the
development of a single subscapular tumour in each
rat by 21 days. This was accompanied by a marked
increase in plasma insulin and decrease in plasma
glucose (73 + 14ngml - I and 2.5+0.4mmolI -1,
n= 12, respectively) compared with control rats
(3.5+0.5ngml-1 and 6.4+0.2mmoll-1, n=12) as
shown in Figure 1. At 21 days the tumour-bearing
rats exhibited greatly reduced pancreatic contents
of insulin and somatostatin (95% and 80%
reductions respectively), and a smaller decrease
(58%) in pancreatic glucagon (Figure 2). In
contrast, the immunoreactive somatostatin and
glucagon contents of selected extra-pancreatic
tissues were not significantly changed in the
tumour-bearing rats (Table I). With the exception
of the pancreas, none of the tissue extracts analysed
contained detectable amounts of immunoreactive
insulin.
Histological and immunocytochemical examina-
tion of sections of pancreas tail 21 days after
tumour transplantation confirmed and extended
the measurements of pancreatic hormone contents.
The islets were reduced in size, and their general
morphology is illustrated by haematoxylin and eosin
staining of a typical atrophic islet in Figure 3a,b.
The islet periphery was irregular, and inspection
of the periphery, expecially under high power
(Figure 3b), revealed detached A cells with pyknotic
nuclei and shrinkage of B cells, some of which
displayed karyorrhetric nuclei. However, B cells
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Figure 1 Effects of tumour resection on plasma concentrations of glucose and insulin in control rats
(O --- 0) and in insulinoma-bearing rats (----- 0). Tumour fragments were transplanted 21 days previously.
The rats were anaesthetised with sodium pentobarbitone (50mgkg-1, i.p.) at approximately -30min. The
tumours were resected and the sham operations were completed at the time indicated by the arrows (Omin).
Values are mean+s.e. of groups of 12 rats. *P<0.05; **P<0.01; ***P<0.001 compared with control rats.
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Figure 2 Immunoreactive insulin, glucagon and
somatostatin in the pancreas of control rats (open
columns) and insulinoma-bearing rats (hatched
columns). Tumour fragments were transplanted 21
days previously. Values are mean+s.e. of groups of 12
rats. *P<0.05; **P<0.01; ***P<0.001, compared
with control rats.
Table I Immunoreactive somatostatin and glucagon in
selected extrapancreatic tissues of control rats and insul-
inoma bearing rats.
Insulinoma-bearing
Control rats rats
Somatostatin (ngg- )
Stomach 36.0+6.0 37.0+7.0
Duodenum 10.5+1.7 9.4+1.6
Jejunum 6.5+1.0 8.1+1.0
Ileum 7.5+0.7 9.3+1.6
Colon 9.8+1.5 13.0+2.7
Kidney 0.8+0.2 0.9+0.1
Hypothalamus 194.0 +20.0 217.0+32.0
Glucagon (ngg-1)
Duodenum 31+10 24+6
Ileum 420+106 471+207
Tumour fragments were transplanted 21 days previ-
ously. Values are mean+s.e. of groups of 12 rats. There
were no significant differences between the immunoreact-
ive somatostatin and glucagon contents of extrapancreatic
tissues in control and insulinoma-bearing rats.
towards the centre of the islet appeared normal.
Immunocytochemical staining for insulin, glucagon
and somatostatin in adjacent sections of the same
islet is shown in Figure 4. Compared with sections
from control rats (Figure 4d), the islets of tumour-
bearing rats revealed a central core of B cells with
weak immunocytochemical staining for insulin
(Figure 4a). Peripherally located glucagon staining
A cells frequently showed degenerative changes
(Figure 4b), while the small number of scattered
and clumped peripheral somatostatin staining
D cells were normal in appearance (Figure 4c).
Although PP containing cells were infrequent in
the pancreas tail of control NEDH rats, islets from
this region were almost entirely devoid of PP cells
in tumour-bearing rats.
Figure 3 Light micrographs of a typical atrophic islet
in the pancreas of a rat transplanted 21 days
previously with insulinoma fragments. (a) shows an
irregular islet periphery with detached A cells with
pyknotic nuclei (H & E, x 313). (b) shows the islet
periphery with shrinkage of B cells some of which
have karyorrhetic nuclei (H & E, x 788).
As shown in Figure 1, surgical resection of the
tumour at day 21 resulted in a prompt and marked
reversal of the metabolic abnormalities of
insulinoma-bearing rats. Plasma insulin concentra-
tions fell rapidly to the range of anaesthetised
controls within 10min, corresponding to an
estimated insulin half-life of -3.5min. Despite this
fall, hypoglycaemia persisted until 60min followed
by hyperglycaemia for 1-2 days. It is noteworthy
that recovery from anaesthesia (approximately 120
minutes) produced a small rise in plasma glucose
concentrations in control rats.
The transient diabetes 1 day after tumour
resection was confirmed by intraperitoneal glucose
tolerance tests (Figure 5a) which showed impaired
glucose homeostasis despite slightly higher plasma
insulin concentrations both before and after admin-
istration of glucose. Evidence for abnormal pan-
creatic B cell function was gained by intraperitoneal
injection of arginine (Figure 5b), which failed to
evoke a plasma insulin response 1 day after
resection.TRANSPLANTABLE RAT INSULINOMA 689
Figure 4 Immunohistochemical staining of specific islet cell hormones in adjacent sections of the islet of the
insulinoma-bearing rat shown in Figure 3. (a) Weakly stained insulin-containing B cells are the predominant
islet cell type. (b) Peripherally located glucagon-staining A cells exhibit degenerative change. (c) Somatostatin-
staining D cells are scattered or clumped at the islet periphery. (d) Islets and B cells in the normal rat
pancreas are larger than those of insulinoma-bearing rats (note different internuclear distance in (a)) and stain
more intensely for insulin. ( x290.)
Two days after tumour resection, basal plasma
glucose and insulin concentrations were similar to
control rats and remained so until day 12 when
basal insulin values were slightly raised (Figure 1).
At this time glucose tolerance was improved
compared with control rats and insulin concentra-
tions remained slightly higher during the test
(Figure 6a). The accelerated rate of glucose
clearance, with the loss of an insulin response to
glucose may provide early evidence of tumour
recurrence. Moreover, the insulin response to
arginine was impaired 12 days after tumour
resection (Figure 6b). A single large tumour was
eventually observed at the original subscapular site
in each of the resected rats. Resection gave a 17-56
day (32+4 day, n=12) prolongation of life (55+4
days since original tumour transplant) compared
with the survival of similarly transplanted
unresected insulinoma-bearing rats (24+ 1 days,
n=9).a
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Figure 5 Plasma concentrations of glucose and insulin in sham-operated control rats (O --- 0) and in ex-
tumour bearing rats 1 day after tumour resection (-----) following i.p. injection of 2 gkg-1 glucose (a;
upper panel) or 2 gkg-1 arginine hydrochloride (b; lower panel). Values are mean + s.e. of groups of 6 rats.
*P<0.05; compared with control rats. +P<0.05 compared with time zero.
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Figure 6 Plasma concentrations of glucose and insulin in sham-operated control rats (O --- 0) and in ex-
tumour bearing rats 12 days after tumour resection (S --- *) following i.p. injection of 2gkg-' glucose (a;
upper panel) or 2gkg-' arginine hydrochloride (b; lower panel). Values are mean+s.e. of groups of 6 rats.
*P<0.05; compared with control rats. +P<0.05 compared with time zero.
Discussion
Consistent with previous reports, subscapular im-
plantation of tumour fragments resulted by 21 days
in the development of a large encapsulated tumour
in each rat with associated hyperinsulinaemia and
hypoglycaemia (Flatt et al., 1986a). The position of
the tumour at the implantation site and the
presence of a connective tissue capsule greatly
facilitated surgical resection. Excision of the tumour
was associated with a prompt and marked reversal
of the abnormalities of glucose homeostasis.
However, despite scrupulous and extensive
cleansing of the excision site, local tumour
recurrence was observed in each rat, with resection
affording a 17-56 day prolongation of life. This
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may reflect direct tissue invasiveness of these
tumours or unavoidable contamination of the sub-
scapular area with tumour cells during the resection
procedure. Indeed, subscapular implantation of a
small number of isolated tumour cells has
previously been shown to reproduce the effects of
routine tumour fragment transplantation (Flatt et
al., 1986b). The observation that tumour recurrence
was restricted to the original subscapular site is
consistent with the very rare tendency of the
tumour to form metastases (Chick et al., 1977;
Flatt et al., 1986b). In this context, it is noteworthy
that plasma insulin concentrations declined rapidly
to the normal range after resection, and that no
detectable insulin was found in the various extra-
pancreatic tissues of tumour-bearing rats.
As noted using routine histological staining,
tumour-bearing rats of the Boston subline exhibited
marked atrophy and degranulation of B cells in the
pancreas (Chick et al., 1977). The present study has
confirmed and extended these observations by
direct hormone assay and specific immunohisto-
chemistry of the principal islet cell types. This
approach demonstrated a generalised atrophy of
the islets associated with irregular peripheral
boundaries containing detached glucagon-
containing A cells with pyknotic nuclei and
shrunken B cells with karyorrhetic nuclei.
Peripheral islet D cells containing somatostatin
appeared normal but the central B cell mass
exhibited a weak immunocytochemical staining for
insulin, and PP-staining cells were reduced in
number. These changes were accompanied by
marked decreases of insulin, glucagon and somato-
statin in the pancreas of the tumour-bearing rats. It
is likely that the hyperinsulinaemia, resulting from
unchecked tumour insulin secretion, and not the
accompanying hypoglycaemia is primarily
responsible for the generalised suppression of islet
cells. Thus unlike glucose which has divergent
effects on islet hormone secretions, insulin inhibits
the secretion of insulin, glucagon, somatostatin,
and PP (Bailey, 1980; Schauder & McIntosh, 1980;
Floyd & Vinik, 1981; Samols et al., 1983), and
specific insulin receptors have been demonstrated
on islet cells (Verspohl & Ammon, 1980; Bhathena
et al., 1982). In contrast to the pancreas, the
glucagon and somatostatin contents of extra-
pancreatic tissues were unchanged in insulinoma-
bearing rats. This clearly reflects the specialised
functions of the pancreatic A and D cells in the
control of islet hormone secretions and the
regulation of nutrient homeostasis.
Resection of the tumour under pentobarbitone
anaesthesia resulted in a marked reduction of
plasma insulin, corresponding to an estimated half-
life of 3.5minutes. This compares favourably with
published values for the disappearance of insulin in
the anaesthetised rat (Izzo, 1975; Frayn, 1976), and
indicates that the hyperinsulinaemia of insulinoma-
bearing rats is maintained by a high rate of insulin
secretion from the tumour. The decline of plasma
insulin after resection was paralleled by a
progressive rise in glycaemia, achieving glucose con-
centrations approximately two-fold higher than
anaesthetised controls by 120 minutes. The
anaesthesia may have contributed to the hyper-
glycaemic action (Bailey & Flatt, 1980). However,
rebound hyperglycaemia persisted for at least 24
hours indicating a brief intervening period of
impaired glucose homeostasis after tumour
removal. This corresponds with earlier observations
in NEDH rats of the Boston subline which were
attributed to suppression of insulin secretion by the
host pancreatic B cells (Chick et al., 1977).
Measurement of plasma insulin concentrations
refutes this view, since at no time following
resection did circulating insulin fall below the range
of control rats. This suggests that impaired action
of insulin rather than impaired secretion is res-
ponsible for the hyperglycaemia. Indeed, it is not
difficult to envisage down-regulation of peripheral
insulin receptors in the hyperinsulinaemic state
(Bailey et al., 1984; Gammeltoft, 1984) which
would recover to restore insulin sensitivity shortly
after resection. This view is supported by impaired
glucose tolerance of 1 day resected rats despite
raised insulin concentrations during the test. How-
ever, insulin secretory responsiveness was also
impaired in these animals, as illustrated by the lack
of effect of arginine. Consistent with tumour
recurrence, the plasma glucose and insulin
responses to these agents had reverted by 12 days
to those typically observed in insulinoma-bearing
rats.
In conclusion, the similarity of the changes
induced by the transplantable NEDH rat insulinoma
to those established from isolated studies in man
(Editorial, 1981; Marks & Rose, 1981; Friesen,
1982), indicates the suitability of these rats as an
animal model for studies on the basic nature and
properties of spontaneous insulinomas. However,
it must be stressed that experimentally-induced
islet-cell tumours differ considerably, and that
careful characterisation of each tumour cell line
must be undertaken to establish its potential useful-
ness. Indeed tumours derived from the same source
may also develop fundamental differences, as illus-
trated by the divergence between the 4-5 month
survival time originally reported (Chick et al., 1977)
and the life expectancy found in the Surrey subline.
These studies were supported by a grant from the Cancer
Research Campaign (SP1630).692 P.R. FLATT et al.
References
BAILEY, C.J. (1980). The hormonal regulation of insulin
secretion. In Biochemistry of Cellular Regulation,
Ashwell, M. (ed), p. 139. CRC Press,: Boca Raton.
BAILEY, C.J. & FLATT, P.R. (1980). Insulin and glucagon
during pentobarbitone anaesthesia. Diabet. Metab., 6,
91.
BAILEY, C.J., LORD, J.M. & ATKINS, T.W. (1984). The
insulin receptor and diabetes. In Recent Advances in
Diabetes, Nattrass, M. & Santiago, J.V. (eds), vol. 1,
p. 27. Churchill Livingstone, Edinburgh.
BHATHENA, S.J., OIE, H.K., GAZDAR, A.F. & 3 others
(1982). Insulin, glucagon and somatostatin receptors
on cultured cells and clones from rat islet cell tumour.
Diabetes, 31, 521.
CHICK, W.L., APPEL, M.C., WEIR, G.C. & 4 others. (1980).
Serially transplantable chemically induced rat islet cell
tumour. Endocrinology, 107, 954.
CHICK, W.L., WARREN, S., CHUTE, R.N. & 3 others.
(1977). A transplantable insulinoma in the rat. Proc.
Natl Acad. Sci. USA, 74, 628.
EDITORIAL. (1981). Insulinomas. Br. Med. J., 282, 927.
FLATT, P.R. & BAILEY, C.J. (1981). Abnormal plasma
glucose and insulin responses in heterozygous (ob/+)
mice. Diabetologia, 20, 573.
FLATT, P.R., BAILEY, C.J., GRAY, C. & 1 other (1986b).
Metabolic effects of a radiation induced rat insulinoma
at pancreatic, hepatic and subscapular transplantation
sites. Comp. Biochem. Physiol. (in press).
FLATT, P.R., BAILEY, C.J., KWASOWSKI, P. & 2 others
(1983). Abnormalities of GIP in spontaneous
syndromes of obesity and diabetes in mice. Diabetes,
32, 433.
FLATT, P.R. & SWANSTON-FLATT, S.K. (1981).
Stimulation of antiglucagon antibodies in rabbits and
guinea pigs using a glucagon-carbodiimide-albumin
conjugate. Endocrinologia experimentalis, 15, 3.
FLATT, P.R., TAN, K.S., SWANSTON-FLATT, S.K. & 2
others (1986a). Defective diurnal changes of food
intake, plasma glucose and insulin in rats with a
transplantable islet cell tumour. Endocrinology
(submitted for publication).
FRAYN, K.N. (1976). Disappearance of 125I-labelled and
unlabelled insulins from blood in normal and injured
rats. Clin. Sci. Molec. Med., 50, 385.
FRIESEN, S.R. (1982). Tumours of the endocrine pancreas.
New Engl. J. Med., 306, 580.
FLOYD, J.C. & VINIK, A.I. (1981). Pancreatic polypeptide.
In Gut Hormones, Bloom, S.R. & Polak, J.M. (eds), p.
195. 2nd edn, Churchill Livingstone: Edinburgh.
GAMMELTOFT, S. (1984). Insulin receptor: Binding
kinetics and structure - function relationship of
insulin. Physiol. Rev., 64, 1321.
GRILLO, T.A.I., WHITTY, A.J., KIRKMAN, H. & 2 others.
(1967). Biological properties of a transplantable islet-
cell tumour in the golden hamster. I. Histology and
histochemistry. Diabetes, 16, 409.
HIRAYAMA, A., WAKABAYASHI, I., MUTO, T. & 2 others
(1979). Histological and hormonal observations on the
BK virus induced pancreatic islet-cell tumours in
hamsters. In Proinsulin, Insulin and C-Peptide.,Baba,
S., et al. (eds), p. 364. Excerpta Medica, Amsterdam.
IZZO, J.L. (1975). Pharmacokinetics of insulin:
Distribution in the organism. In Handbook of
Experimental Pharmacology, Hasselblatt, A. &
Bruchhausen, F.V. (eds), vol. 32, p. 195. Springer-
Verlag: Berlin.
J0RGENSEN, K.H. & LARSEN, U.D. (1972). Purification of
'25I-glucagon by anion exchange chromatography.
Hormone Metab. Res., 4, 223.
MARKS, V. & ROSE, F.C. (1981). Hypoglycaemia, 2nd edn.
Blackwell Scientific Publications, Oxford.
PENMAN, E., WASS, J.A.H., LUND, A. & 5 others (1979).
Development and validation of a specific
radioimmunoassay for somatostatin in human plasma.
Ann. Clin. Biochem., 16, 15.
SAMOLS, E., WEIR, G.C. & BONNER-WEIR, S. (1983).
Intraislet insulin-glucagon-somatostatin relationships.
In Glucagon II, Lefebvre, P.J. (ed), p. 133. Springer-
Verlag: Berlin.
SCHAUDER, P. & McINTOSH, C. (1980). SRIF secretion by
isolated islets. In Diabetes 1979, Waldhausl, W.K. (ed),
p. 446. Excerpta Medica: Amsterdam.
STERNBERGER, L.A. (1979). Immunocytochemistry, 2nd
edn. Wiley & Sons: New York.
STEVENS, J.F. (1971). Determination of glucose by an
automatic analyser. Clin. Chim. Acta, 32, 199.
VERSPOHL, E.J. & AMMON, H.P.T. (1980). Evidence for
presence of insulin receptors in rat islets of
Langerhans. J. Clin. Invest., 65, 1230.